Clinical Associate Professor Harry Iland
C39 - Royal Prince Alfred Hospital
The University of Sydney NSW 2006 Australia |
|
His main interests have encompassed molecular abnormalities in haematological malignancies, and he established one of the earliest molecular diagnostic laboratories for haematological malignancy in Australia. In the last few years he has been responsible for the Australasian Leukaemia and Lymphoma Group’s clinical trial program in acute promyelocytic leukaemia (APL), and has combined this with an active laboratory program in the molecular analysis of APL cells. His laboratory has also established molecular assays relevant for patients with idiopathic hypereosinophilic syndrome / chronic eosinophilic leukaemia.
2009
- de Zwaan, S, Iland, H, Damian, D. Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin. The Australasian Journal of Dermatology. 2009; 50:56-59
2007
- Catalano, A, Dawson, M, Somana, K, Opat, S, Schwarer, A, Campbell, L, Iland, H. The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia. Blood. 2007; 110:4073-6
- Sanders, J, Crawford, B, Gibson, J, Joy Ho, P, Iland, H, Joshua, D. Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS). International journal of laboratory hematology. 2007. p. 395-397.
- Young, G, Iland, H. Clinical perspectives in lymphoma. Internal medicine journal. 2007; 37:478-484
2006
- Ling, S, Joshua, D, Gibson, J, Young, G, Iland, H, Watson, G, Ho, P. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?. American journal of hematology. 2006; 81:110-4
2005
- Catalano, A, Iland, H. Molecular biology of lymphoma in the microarray era. Pathology. 2005; 37:508-22
- Iland, H, Hertzberg, M, Marlton, P. Myeloid Leukemia: Methods and Protocols. Totowa, New Jersey: Humana Press, 2005.
2002
- Applegate, T, Iland, H, Mokany, E, Todd, A. Molecular monitoring of acute promyelocytic leukemia by DzyNA reverse transcription-PCR. Clinical Chemistry. 2002; 48:1858-1860
2001
- Supple, S, Iland, H, Barnett, M, Pollard, J. A spontaneous novel XK gene mutation in a patient with McLeod syndrome. British Journal of Haematology. 2001; 115:369-372
- Ho, L, Ayling, J, Prosser, I, Kronenberg, H, Iland, H, Joshua, D. Missense C168T in the Wiskott--Aldrich Syndrome protein gene is a common mutation in X-linked thrombocytopenia. British Journal of Haematology. 2001; 112:76-80
2000
- Iland, H. Detection of minimal residual disease in hematologic malignancies by molecular technology. In: Clinical Bone Marrow and Blood Stem Cell Transplantation, 2nd edn. : Cambridge University Press 2000. p. 1380-1393.
